Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Intertek Supports Innovation and Advancements in Nanotechnology

Intertek
Posted on: 20 Oct 16

Intertek, a leading Total Quality Assurance provider to industries worldwide, has collaborated with OCSiAl’s Health and Safety Department and its European service provider, Envigo, to prove that TUBALL™ single wall carbon nanotubes fully comply with EU REACH requirements.

Intertek was contracted by OCSiAl, the world's first manufacturer of single wall carbon nanotubes (SWCNT), to work with the European Chemicals Agency (ECHA) to provide the required chemical safety data and reports. Intertek scientific and regulatory experts were ultimately responsible for the preparation of the robust REACH registration dossier and the coordination of the phys-chem, tox, and eco-tox testing done with Envigo.

The successful registration of TUBALL™ under number 01-2120130006-75-0000 proves that TUBALL™ SWCNT fully comply with REACH requirements, and are now available at industrial volumes. This is a significant milestone for OCSiAl and will increase awareness, within the European market, and the global community, providing a more comprehensive understanding of nanotubes, and nanotube management worldwide. In addition, this process will support the expansion of mass applications of SWCNT applications in a wide range of industries, including consumable products.

Ms. Manuela Corrazza, Intertek Health Environmental & Regulatory Services Operations Manager Italy, states,Over the course of 6 months, through the collaboration with OCSiAl and Envigo, we were able to produce the technical, and highly detailed, description of SWCNT, including features, potential risks, and specifications for particular methods of risk management. REACH registration is a comprehensive process that requires compliance with the highest of standards and we are delighted to be part of this industry-first innovation.”

Intertek offers full registration services under REACH. This includes development of the technical dossier, Chemical Safety Assessment (CSA), exposure scenarios, Persistent, Bioaccumulative and Toxic (PBT) assessments and preparation of extended Safety Data Sheets. Our REACH services are delivered by a dedicated European based team, supported by a global network of experts in risk assessment, toxicology, eco-toxicology and testing. To learn more about the compliance services offered by our scientific and regulatory consultants and from the larger Intertek organization, please visit www.intertek.com/reach.

About Intertek

Intertek is a leading Total Quality Assurance provider to industries worldwide. Our network of more than 1,000 laboratories and offices and over 40,000 people in more than 100 countries, delivers innovative and bespoke Assurance, Testing, Inspection and Certification solutions for our customers’ operations and supply chains.

www.intertek.com

Bringing quality and safety to life

View source version on businesswire.com: http://www.businesswire.com/news/home/20161020005097/en/

Business Wire
www.businesswire.com

Last updated on: 20/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.